Close Menu

NEW YORK (GenomeWeb) – Horizon Discovery today announced a deal for the marketing of its X-MAN human haploid and diploid isogenic cell line collection by Thermo Fisher Scientific. 

Under the supply and commercialization agreement, Thermo Fisher will also further offer Horizon's X-MAN haploid cell line generation service to its worldwide customer base. Thermo Fisher will use its e-commerce and direct sales channels to make the products and services available to the research community. 

Financial and other terms were not disclosed. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.